flortaucipir (Tauvid) Report issue

Small molecule Imaging Approved FDA Priority Review FDA
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: [18F]c1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1
  • InChIKey: GETAAWDSFUCLBS-SJPDSGJFSA-N
  • Mol. Mass: 262.28
  • ALogP: 3.92
  • ChEMBL Molecules:
    flortaucipir f 18  
    flortaucipir  
More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Imaging: 18-fluorine
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

(18)av-1451 | (18f)1451 | 18f av 1451 | 18f-av-1451 | 18f t807 | (18f)t807 compound | 7-(6-fluoropyridin-3-yl)-5h-pyrido(4,3-b)indole | av1451 | av-1451 | (f-18)-av-1451 | f-18-av-1451 | t807 | t-807

Organizations (34)

Research & Development (33)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (25)

Approved Indications (3)


 

Alzheimer Disease (approved 2020)

Chronic Traumatic Encephalopathy

Cognitive Dysfunction

Experimental Indications - Clinical Trial Phases 1-4 (25)


 

Alzheimer Disease (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Atrophy (Phase 2)

Brain Concussion (Phase 1)

Brain Injuries, Traumatic (Phase 2)

Chronic Traumatic Encephalopathy (Phase 2)

Cognition Disorders (Phase 1)

Cognitive Dysfunction (Phase 2)

Corticobasal Degeneration (Phase 1)

Dementia (Phase 2)

Dementia, Vascular (Phase 4)

Depression (Phase 2)

Frontal Lobe (Phase 2)

Frontotemporal Dementia (Phase 4)

HIV (Phase 2)

Lewy Body Disease (Phase 4)

Malformations of Cortical Development (Phase 2)

Neurodegenerative Diseases (Phase 2/Phase 3)

Neuroimaging (Phase 4)

Parkinson Disease (Phase 1)

Pick Disease of the Brain (Phase 1)

Supranuclear Palsy, Progressive (Phase 1)

Tauopathies (Phase 2)

Traumatology (Phase 1)

Whole Body Imaging (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 54
  • # of Trial Organizations: 33

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue